InMed Pharmaceuticals 배당금
배당금 기준 확인 0/6
InMed Pharmaceuticals does not have a record of paying a dividend.
주요 정보
n/a
배당 수익률
-133.8%
환매 수익률
| 총 주주 수익률 | -133.8% |
| 미래 배당 수익률 | n/a |
| 배당금 성장 | n/a |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | n/a |
| 지급 비율 | n/a |
최근 배당금 업데이트
업데이트 없음
Recent updates
InMed Pharmaceuticals GAAP EPS of -$33.17, revenue of $1.09M
Sep 26InMed Pharma announces $6M private placement
Sep 09InMed Pharma says phase 2 trial for skin disorder cannabinol cream can now include teens
Jul 25InMed Pharmaceuticals gets non-compliance notice on Nasdaq minimum bid price requirement
Jul 13InMed To Acquire Rare Cannabinoid Manufacturer BayMedica
Jul 02InMed's INM-755 CBN cream did not introduce any delay in normal wound healing
Jan 08결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Insufficient data to determine if INM's dividends per share have been stable in the past.
배당금 증가: Insufficient data to determine if INM's dividend payments have been increasing.
시장 대비 배당 수익률
| InMed Pharmaceuticals 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (INM) | n/a |
| 시장 하위 25% (US) | 1.5% |
| 시장 상위 25% (US) | 4.5% |
| 업계 평균 (Pharmaceuticals) | 2.3% |
| 애널리스트 예측 (INM) (최대 3년) | n/a |
주목할만한 배당금: Unable to evaluate INM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
고배당: Unable to evaluate INM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
주주에 대한 수익 배당금
수익 보장: Insufficient data to calculate INM's payout ratio to determine if its dividend payments are covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: Unable to calculate sustainability of dividends as INM has not reported any payouts.